Bellevue Group’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78M | Hold |
2,733,547
| – | – | 0.15% | 74 |
|
|
2025
Q1 | $4.24M | Sell |
2,733,547
-5,784,292
| -68% | -$8.97M | 0.09% | 90 |
|
|
2024
Q4 | $18.2M | Hold |
8,517,839
| – | – | 0.35% | 65 |
|
|
2024
Q3 | $37.1M | Hold |
8,517,839
| – | – | 0.6% | 49 |
|
|
2024
Q2 | $39.7M | Hold |
8,517,839
| – | – | 0.65% | 45 |
|
|
2024
Q1 | $43.2M | Sell |
8,517,839
-18,000
| -0.2% | -$91.3K | 0.66% | 48 |
|
|
2023
Q4 | $24M | Buy |
8,535,839
+400,000
| +5% | +$1.12M | 0.37% | 69 |
|
|
2023
Q3 | $23.3M | Hold |
8,135,839
| – | – | 0.38% | 71 |
|
|
2023
Q2 | $41.1M | Buy |
8,135,839
+2,740,000
| +51% | +$13.8M | 0.59% | 57 |
|
|
2023
Q1 | $10.2M | Sell |
5,395,839
-5,000
| -0.1% | -$9.45K | 0.15% | 94 |
|
|
2022
Q4 | $9.72M | Buy |
5,400,839
+683,726
| +14% | +$1.23M | 0.13% | 100 |
|
|
2022
Q3 | $7.97M | Hold |
4,717,113
| – | – | 0.11% | 102 |
|
|
2022
Q2 | $11.6M | Buy |
4,717,113
+1,424,113
| +43% | +$3.5M | 0.16% | 103 |
|
|
2022
Q1 | $9.12M | Sell |
3,293,000
-170,000
| -5% | -$471K | 0.11% | 108 |
|
|
2021
Q4 | $18.5M | Hold |
3,463,000
| – | – | 0.19% | 103 |
|
|
2021
Q3 | $29.3M | Hold |
3,463,000
| – | – | 0.3% | 91 |
|
|
2021
Q2 | $42.2M | Buy |
3,463,000
+1,220,000
| +54% | +$14.9M | 0.41% | 75 |
|
|
2021
Q1 | $54.4M | Buy |
2,243,000
+840,000
| +60% | +$20.4M | 0.58% | 56 |
|
|
2020
Q4 | $45M | Hold |
1,403,000
| – | – | 0.52% | 56 |
|
|
2020
Q3 | $42.4M | Hold |
1,403,000
| – | – | 0.59% | 49 |
|
|
2020
Q2 | $59.2M | Buy |
1,403,000
+73,000
| +5% | +$3.08M | 0.84% | 32 |
|
|
2020
Q1 | $33.2M | Buy |
+1,330,000
| New | +$33.2M | 0.64% | 44 |
|